ASC-directed nanobodies reduce inflammasome signaling and improve outcome after experimental ischemic stroke

Background: Inflammasome activation contributes to ischemic brain injury, but therapeutic efforts have focused almost exclusively on individual upstream sensors such as NLR family pyrin domain-containing 3 (NLRP3). Because the inflammatory landscape shifts as persistent vessel occlusion gives way to reperfusion, inhibiting one sensor may protect incompletely. Methods: We targeted apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), the adaptor shared by multiple canonical inflammasomes, using a camelid-derived single-domain antibody (nanobody), VHH(mASC), in two complementary mouse models of ischemic stroke: permanent middle cerebral artery occlusion without reperfusion, and transient occlusion followed by reperfusion. Results: Applied before ischemia, during persistent occlusion, or immediately after reperfusion, VHH(mASC) reduced infarct volume by up to 61% and improved neurological function in every paradigm. Fluorescently labeled nanobody was enriched within ischemic brain tissue, and treatment lowered cerebral ASC abundance. ASC-positive neutrophils predominated during occlusion, whereas ASC-positive neurons and microglia were most abundant at the later time point afterreperfusion. Treatment attenuated signaling associated with NLRP3 and with absent in melanoma 2 (AIM2), and reduced caspase-1 activation, interleukin-1β maturation and gasdermin D (GSDMD) cleavage. Conclusions: ASC-directed nanobodies limit inflammasome signaling and improve outcome in acute ischemic stroke whether or not the occluded vessel is reopened, establishing adaptor-level inhibition as a strategy distinct from targeting individual sensors.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11636317/v1
Primary Topic
Inflammasome and immune disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

ASC-directed nanobodies reduce inflammasome signaling and improve outcome after experimental ischemic stroke

Maximilian Bellut, Florian Ingo Schmidt, Bernardo S. Franklin, Salie Maasewerd et al.
Research Square
Inflammasome and immune disorders
preprint

ASC-directed nanobodies reduce inflammasome signaling and improve outcome after experimental ischemic stroke

Maximilian Bellut, Florian Ingo Schmidt, Bernardo S. Franklin, Salie Maasewerd, Lukas Roßnagel, Milena Strootmann
preprint en

Abstract

Background: Inflammasome activation contributes to ischemic brain injury, but therapeutic efforts have focused almost exclusively on individual upstream sensors such as NLR family pyrin domain-containing 3 (NLRP3). Because the inflammatory landscape shifts as persistent vessel occlusion gives way to reperfusion, inhibiting one sensor may protect incompletely. Methods: We targeted apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), the adaptor shared by multiple canonical inflammasomes, using a camelid-derived single-domain antibody (nanobody), VHH(mASC), in two complementary mouse models of ischemic stroke: permanent middle cerebral artery occlusion without reperfusion, and transient occlusion followed by reperfusion. Results: Applied before ischemia, during persistent occlusion, or immediately after reperfusion, VHH(mASC) reduced infarct volume by up to 61% and improved neurological function in every paradigm. Fluorescently labeled nanobody was enriched within ischemic brain tissue, and treatment lowered cerebral ASC abundance. ASC-positive neutrophils predominated during occlusion, whereas ASC-positive neurons and microglia were most abundant at the later time point afterreperfusion. Treatment attenuated signaling associated with NLRP3 and with absent in melanoma 2 (AIM2), and reduced caspase-1 activation, interleukin-1β maturation and gasdermin D (GSDMD) cleavage. Conclusions: ASC-directed nanobodies limit inflammasome signaling and improve outcome in acute ischemic stroke whether or not the occluded vessel is reopened, establishing adaptor-level inhibition as a strategy distinct from targeting individual sensors.

Research Square
University of Bonn (DE), Universitätsklinikum Würzburg (DE)
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon